Small Cap Value Premium

Among the equity factors that academic research has identified — size, value, momentum, quality, and others — small-cap value has the strongest historical record. Over the long run (decades), small-cap value stocks have outperformed the broader market by 2–4 percentage points per year. The mechanism is debated; the data is consistent across multiple countries and multiple decades.

The complication: the premium has been weaker over the last 15 years, especially in US markets, leading some investors to question whether it still exists. This page is about what the premium is, what the recent underperformance might mean, and how to actually access the factor if you want to.

What "small-cap value" means

Two factor exposures combined:

Size factor

Smaller companies (by market capitalization) have historically outperformed larger companies. The effect is most pronounced at the smaller end (small-cap and micro-cap) and weakens for mid-caps.

Value factor

Cheaper companies (by metrics like price-to-book, price-to-earnings, dividend yield) have historically outperformed more expensive companies. "Cheap" here is defined by traditional value metrics, not by judgment about the underlying business.

Combined

Stocks that are both small *and* cheap have produced even higher historical returns than either factor alone. The combination is more pronounced than the sum of the individual factors.

The historical record

Over 1928–2020 in the US:

- US large-cap broad market: ~10% nominal return

- US large-cap value: ~11.5%

- US small-cap broad: ~12%

- US small-cap value: ~13.5%

The 3.5 percentage point spread between large-cap broad and small-cap value compounded over a 40-year career produces roughly 3.5x more wealth — a substantial difference.

International data shows similar but somewhat weaker effects. The premium exists in most developed markets and most decades.

The recent decade

From roughly 2008–2023, US small-cap value underperformed US large-cap growth by a large margin. The reasons advanced include:

- The dominance of large-cap technology in this era

- Growth-stock multiple expansion (lower discount rates favored growth stocks)

- Specific cyclical factors

Whether this represents a temporary deviation or a permanent change in the premium is unsettled. Two views:

"The premium is dead"

The argument: factor premiums get arbitraged away once they are widely known. Once enough investors tilt toward small-cap value, the premium evaporates because the prices of those stocks are bid up.

This argument has some merit but is undermined by the persistence of the premium across decades and the fact that it has weakened-then-recovered multiple times historically.

"It is mean-reverting"

The argument: the premium is real but cyclical. Periods of underperformance are followed by periods of outperformance. The 2008–2023 underperformance is not unprecedented; similar stretches have happened before, and recoveries have followed.

This view is the more common among academic researchers who built the factor models. It implies the premium will return, though timing is uncertain.

The honest answer: nobody knows. Investors choosing to tilt toward small-cap value are making a judgment call that the long-run premium will continue.

How to access small-cap value in a portfolio

Index ETFs

The most straightforward approach. Specific funds:

- **AVUV** (Avantis US Small Cap Value) — 0.25%, often considered the best implementation

- **DFSV** (Dimensional US Small Cap Value) — 0.31%, from Dimensional Fund Advisors

- **VBR** (Vanguard Small-Cap Value) — 0.07%, broader and less concentrated

- **SLYV** (SPDR S&P 600 Small Cap Value) — 0.15%

The differences between these funds are real:

- **AVUV/DFSV** target the factor more aggressively (deeper value, smaller caps); higher expected factor exposure but higher fees

- **VBR/SLYV** are broader and cheaper; weaker factor exposure but lower cost

For investors specifically wanting factor exposure, AVUV is often considered the best option. For investors wanting modest tilt at low cost, VBR works.

International small-cap value

If you want the factor outside US markets:

- **AVDV** (Avantis International Small Cap Value) — 0.36%

- **DISV** (Dimensional International Small Cap Value) — 0.45%

- Vanguard does not have a clean international small-cap value fund

As part of a multi-factor fund

Some funds combine multiple factors (size, value, quality, momentum) in one product. AVUV is technically a multi-factor fund; explicit "factor stack" funds exist but tend to be expensive.

Sizing the allocation

If you choose to tilt toward small-cap value, the question is how much.

A modest tilt (5–15% of equity)

Adds factor exposure without dramatically changing the portfolio's character. The most common approach. Low risk that the tilt dominates the experience if the factor underperforms.

A substantial tilt (20–40% of equity)

For investors with strong factor convictions. Provides meaningful exposure but accepts substantial tracking error vs. broad market.

Heavy tilt (50%+)

Rare; typically only for investors with very strong factor convictions and long horizons. Accepts the possibility of decade-plus periods of underperformance.

The patience requirement

Factor investing requires patience. The premium materializes over decades, not years. An investor adding small-cap value at the wrong moment can experience 5–15 years of underperformance before the factor returns.

This is the single biggest behavioral challenge with factor investing: the conviction that the long-run return premium is real has to survive multi-year periods where the tilt is hurting performance.

If you would not hold a small-cap value fund through 10+ years of underperforming the broader market, you should not buy one. The factor premium is paid for by the willingness to hold through bad periods.

Common failure patterns

- **Buying after a stretch of outperformance.** The factor is mean-reverting; buying after strong performance often catches the wrong end of the cycle.

- **Selling during periods of underperformance.** Similar mistake on the other side.

- **Comparing factor funds to broad market on short horizons.** The premium materializes over decades.

- **Holding factor funds in taxable accounts without considering tax efficiency.** Some factor funds have high turnover; tax drag can offset factor gains.

- **Stacking too many factors into a complex portfolio.** Each additional factor adds tracking error and complexity. For most investors, a single factor tilt (small-cap value) is plenty.

A reasonable conclusion

For investors who want exposure to the strongest equity factor:

- 5–15% of equity in a low-cost small-cap value fund (AVUV or VBR)

- Hold in tax-advantaged accounts where possible

- Plan to hold for decades; do not sell during underperformance

- Accept that the premium may not show up over your specific horizon

For investors who want simplicity and acceptable returns without factor bets:

- Just hold broad-market index funds

- The implicit factor exposure (you have *some* small and *some* value in a total-market fund) is enough for most purposes

Both approaches are defensible. Heavy factor tilting requires conviction and patience; choosing not to tilt requires accepting that you might leave 1–3% of expected return on the table over the long run.